Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency - Takeaways - MDSpire

Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency

Share

1

Vinay Prasad is leaving the FDA at the end of April, marking his second departure from the agency.
2

Prasad's tenure included reducing clinical trial requirements and overseeing the regulation of vaccines and gene therapies.
3

His leadership faced criticism for rejecting several rare disease drugs, raising concerns among patient advocates.
4

Prasad's management style reportedly created a work environment of mistrust, leading to multiple complaints from staff.
5

FDA Commissioner Marty Makary praised Prasad's accomplishments but acknowledged the controversies surrounding his decisions.